Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash and Bank

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash and Bank ₹1,705 Cr₹1,659 Cr₹1,160 Cr₹1,412 Cr₹1,139 Cr

What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Cash and Bank
Mar2025₹1,705 Cr
Mar2024₹1,659 Cr
Mar2023₹1,160 Cr
Mar2022₹1,412 Cr
Mar2021₹1,139 Cr

How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?

Years Cash and Bank % Change
Mar2025 ₹1,705 Cr
2.76
Mar2024 ₹1,659 Cr
43.02
Mar2023 ₹1,160 Cr
-17.80
Mar2022 ₹1,412 Cr
23.91
Mar2021 ₹1,139 Cr -

Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,325.9 Cr 4.9% 6% 63.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.9%

6%

63.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses